Abingdon Health PLC (AIM:ABDX) Judicial Review – judgement expected

York, U.K. 7 October 2022: Abingdon Health plc (AIM: ABDX), a leading international developer and manufacturer of high-quality and effective rapid tests, notes that a judgement in relation to the Judicial Review proceedings initiated by the Good Law Project Limited (“GLP”) against the Department of Health and Social Care (“DHSC”) is expected to be handed down today at 12noon.

Abingdon Health is an interested party in the case.

Details are provided in section 17.4 of this link:

https://www.gov.uk/government/publications/business-and-property-courts-rolls-building-cause-list/business-and-property-courts-of-england-and-wales-cause-list#technology-and-construction-court-kings-bench-division

A further announcement will be made once the outcome of the Judicial Review is known.

Enquiries

Abingdon Health plc

www.abingdonhealth.com/investors/

Chris Yates, Chief Executive Officer

Via Walbrook PR

Melanie Ross , Chief Financial Officer

Chris Hand, Non-Executive Chairman